HSR25-178: Initial Clinical Presentation (ICP) and Pre-Diagnostic Journey During 18 Months Before a First Non-Small Cell Lung Cancer (NSCLC) Diagnosis: US Retrospective Cohort Study
"HSR25-178: Initial Clinical Presentation (ICP) and Pre-Diagnostic Journey During 18 Months Before a First Non-Small Cell Lung Cancer (NSCLC) Diagnosis: US Retrospective Cohort Study" published on 28 Mar 2025 by National Comprehensive Cancer Network.
Authors
- Melissa L. Santorelli (ORCID: https://orcid.org/0000-0002-2964-7292)
- Molly Scannell Bryan (ORCID: https://orcid.org/0000-0003-1030-3155)
- Xiaohan Hu (ORCID: https://orcid.org/0000-0002-5608-2864)
- Connor Sweetnam (ORCID: https://orcid.org/0000-0002-4275-0569)
- Lori Boice
- Monika A. Izano (ORCID: https://orcid.org/0000-0003-1852-5342)
- Ashwini Arunachalam (ORCID: https://orcid.org/0000-0003-4879-4770)
- Ronda Broome
- Ashleigh E. McBratney (ORCID: https://orcid.org/0000-0003-1703-8032)
- Kristiana Wilkinson
- Anna B. Berry (ORCID: https://orcid.org/0000-0002-9246-4560)
Institutions
- Merck & Co., Inc., Rahway, NJ, USA (United States) (US)
Publication Details
- Journal
- Journal of the National Comprehensive Cancer Network
- Published
- 2025-03-28
- DOI
- https://doi.org/10.6004/jnccn.2024.7265
- Primary Topic
- Lung Cancer Treatments and Mutations
- Type
- article
- Field-Weighted Citation Impact
- 0.00